About Us
Terms & Conditions
Privacy Policy
FAQ
Contact Us
Careers
Advertise
Download The App
Car Sticker
Community
Copyright © BFM Media Sdn Bhd (200601017962)
Play the Live Stream or select a Podcast to play
0:00
0:00
0:00
0:00
Play the Live Stream or select a Podcast to play
0:00
0:00
0:00
0:00
ADVERTISEMENT
morning-run · the-breakfast-grille · 9 Sept 2014 · 10:55 am · 23 mins listen
In this 2014 interview, David Ho, Chairman and Managing Director of the pharmaceuticals firm Hovid Berhad, discusses global M&A fever in Big Pharma, offers an update on its latest quarterly earnings, its product mix, ongoing industry drivers and challenges and the importance of its ongoing R&D efforts such as its Tocotrienol drug.
Related Content
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT